Testing a new hepatitis A vaccine in healthy people
Treatments studied
Part of Digestive system clinical trials.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 1 year old or older and in good health.
- You should not have had a hepatitis A vaccine or hepatitis A infection before.
- You should not have any known allergies to vaccine ingredients.
- You should not have autoimmune or immune deficiency diseases, or poorly controlled chronic conditions.
- Women who can become pregnant must agree to use contraception during the study and for 30 days after the second shot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine designed to prevent hepatitis C, a virus that affects the liver. The goal is to see if the vaccine is safe, and to understand how the body's immune system responds to it.
This study checks whether a single dose of the hepatitis A vaccine helps protect people with cirrhosis who have no immunity. It aims to see how well the vaccine works and your body's response.
This study is looking at how the immune system responds in children with acute hepatitis A (a liver infection). Participation may help doctors better understand the body's natural defenses and improve care for other children.
This study tests a new hepatitis B vaccine to see if it is safe and helps the body fight the virus. It is for healthy people who have not had a hepatitis B vaccine in the last 10 years.
This trial tests a new way of giving the hepatitis B vaccine using a patch with tiny needles that goes on the skin. For healthy adults who have not been vaccinated against hepatitis B since childhood, this could be a more comfortable and easier way to protect against the infection.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
Hear when a new Hepatitis A Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.